Technical Analysis for PTGX - Protagonist Therapeutics, Inc.

Grade Last Price % Change Price Change
C 29.35 5.16% 1.44
PTGX closed up 5.16 percent on Thursday, April 22, 2021, on 1.12 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: May 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical PTGX trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish 5.16%
Crossed Above 50 DMA Bullish 5.16%
MACD Bullish Signal Line Cross Bullish 5.16%
Older End-of-Day Signals for PTGX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1 ATR about 22 hours ago
Up 5% about 22 hours ago
60 Minute Opening Range Breakout about 22 hours ago
Up 3% about 23 hours ago
Up 2% about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The Company's initial lead product candidates consists of PTG-100 and PTG-200, which have the potential to transform the existing treatment paradigm for inflammatory bowel disease, a GI disease consisting primarily of ulcerative colitis and Crohn's disease; PTG-300, an injectable hepcidin mimetic. Protagonist Therapeutics, Inc. is based in Milpitas, United States.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Immunology Autoimmune Diseases Proprietary Technology Inflammatory Bowel Disease Ulcer Colitis Ulcerative Colitis Abdominal Pain Crohn's Disease EPC Chemical Entities Epci Gi Disease Hepcidin

Is PTGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.1
52 Week Low 6.13
Average Volume 334,444
200-Day Moving Average 22.25
50-Day Moving Average 27.40
20-Day Moving Average 26.58
10-Day Moving Average 26.75
Average True Range 1.63
ADX 23.1
+DI 23.38
-DI 18.95
Chandelier Exit (Long, 3 ATRs ) 26.53
Chandelier Exit (Short, 3 ATRs ) 29.03
Upper Bollinger Band 28.60
Lower Bollinger Band 24.57
Percent B (%b) 1.19
BandWidth 15.18
MACD Line 0.02
MACD Signal Line -0.24
MACD Histogram 0.2553
Fundamentals Value
Market Cap 1.12 Billion
Num Shares 38.3 Million
EPS -2.74
Price-to-Earnings (P/E) Ratio -10.70
Price-to-Sales 26.02
Price-to-Book 4.80
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.79
Resistance 3 (R3) 32.65 31.36 32.21
Resistance 2 (R2) 31.36 30.49 31.43 32.02
Resistance 1 (R1) 30.36 29.95 30.86 30.50 31.83
Pivot Point 29.07 29.07 29.33 29.14 29.07
Support 1 (S1) 28.07 28.20 28.57 28.21 26.87
Support 2 (S2) 26.78 27.66 26.85 26.68
Support 3 (S3) 25.78 26.78 26.49
Support 4 (S4) 25.92